{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T06:52:28Z","timestamp":1794466348571,"version":"4.9.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T00:00:00Z","timestamp":1540252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T00:00:00Z","timestamp":1540252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Persistent or recurrent retinoblastoma (RB) is associated with the presence of vitreous or\/and subretinal seeds in advanced RB and represents a major cause of therapeutic failure. This necessitates the development of novel therapies and thus requires a model of advanced RB for testing candidate therapeutics. To this aim, we established and characterized a three-dimensional, self-organizing organoid model derived from chemotherapy-na\u00efve tumors. The responses of organoids to drugs were determined and compared to relate organoid model to advanced RB, in terms of drug sensitivities. We found that organoids had histological features resembling retinal tumors and seeds and retained DNA copy-number alterations as well as gene and protein expression of the parental tissue. Cone signal circuitry (M\/L<jats:sup>+<\/jats:sup> cells) and glial tumor microenvironment (GFAP<jats:sup>+<\/jats:sup> cells) were primarily present in organoids. Topotecan alone or the combined drug regimen of topotecan and melphalan effectively targeted proliferative tumor cones (RXR\u03b3<jats:sup>+<\/jats:sup> Ki67<jats:sup>+<\/jats:sup>) in organoids after 24-h drug exposure, blocking mitotic entry. In contrast, methotrexate showed the least efficacy against tumor cells. The drug responses of organoids were consistent with those of tumor cells in advanced disease. Patient-derived organoids enable the creation of a faithful model to use in examining novel therapeutics for RB.<\/jats:p>","DOI":"10.1038\/s41598-018-34037-y","type":"journal-article","created":{"date-parts":[[2018,10,17]],"date-time":"2018-10-17T15:25:18Z","timestamp":1539789918000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":70,"title":["A three-dimensional organoid model recapitulates tumorigenic aspects and drug responses of advanced human retinoblastoma"],"prefix":"10.1038","volume":"8","author":[{"given":"Duangporn","family":"Saengwimol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duangnate","family":"Rojanaporn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijender","family":"Chaitankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamorn","family":"Chittavanich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rangsima","family":"Aroonroch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatpong","family":"Boontawon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weerin","family":"Thammachote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natini","family":"Jinawath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suradej","family":"Hongeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossukon","family":"Kaewkhaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,23]]},"reference":[{"key":"34037_CR1","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1001\/archopht.120.4.460","volume":"120","author":"CL Shields","year":"2002","unstructured":"Shields, C. L. et al. Factors predictive of recurrence of retinal tumors, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma. Arch. Ophthalmol. 120, 460\u2013464 (2002).","journal-title":"Arch. Ophthalmol."},{"key":"34037_CR2","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1016\/j.ophtha.2004.04.016","volume":"111","author":"K G\u00fcnd\u00fcz","year":"2004","unstructured":"G\u00fcnd\u00fcz, K. et al. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation. Ophthalmology 111, 1917\u20131924 (2004).","journal-title":"Ophthalmology"},{"key":"34037_CR3","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1016\/j.ophtha.2017.05.034","volume":"124","author":"JL Berry","year":"2017","unstructured":"Berry, J. L. et al. Not all seeds are created equal: seed classification is predictive of outcomes in retinoblastoma. Ophthalmology 124, 1817\u20131825 (2017).","journal-title":"Ophthalmology"},{"key":"34037_CR4","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1001\/archophthalmol.2012.1983","volume":"130","author":"F Ghassemi","year":"2012","unstructured":"Ghassemi, F. & Shields, C. L. Intravitreal melphalan for refractory or recurrent vitreous seeding from retinoblastoma. Arch. Ophthalmol. 130, 1268\u20131271 (2012).","journal-title":"Arch. Ophthalmol."},{"key":"34037_CR5","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1001\/jamaophthalmol.2013.7666","volume":"132","author":"CL Shields","year":"2014","unstructured":"Shields, C. L. et al. Intravitreal melphalan for persistent or recurrent retinoblastoma vitreous seeds: preliminary results. JAMA Ophthalmol. 132, 319\u2013325 (2014).","journal-title":"JAMA Ophthalmol."},{"key":"34037_CR6","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1136\/bjophthalmol-2017-310861","volume":"102","author":"R Rao","year":"2018","unstructured":"Rao, R., Honavar, S. G., Sharma, V. & Reddy, V. A. P. Intravitreal topotecan in the management of refractory and recurrent vitreous seeds in retinoblastoma. Br. J. Ophthalmol. 102, 490\u2013495 (2018).","journal-title":"Br. J. Ophthalmol."},{"key":"34037_CR7","doi-asserted-by":"publisher","first-page":"423","DOI":"10.5301\/ejo.5000921","volume":"27","author":"H Kiratli","year":"2017","unstructured":"Kiratli, H., Ko\u00e7, \u0130., Varan, A. & Aky\u00fcz, C. Intravitreal chemotherapy in the management of vitreous disease in retinoblastoma. Eur. J. Ophthalmol. 27, 423\u2013427 (2017).","journal-title":"Eur. J. Ophthalmol."},{"key":"34037_CR8","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1080\/13816810.2018.1443343","volume":"39","author":"DH Abramson","year":"2018","unstructured":"Abramson, D. H., Catalanotti, F., Brodie, S. E., Kellick, M. G. & Francis, J. H. Intravitreal chemotherapy and laser for newly visible subretinal seeds in retinoblastoma. Ophthalmic Genet. 39, 353\u2013356 (2018).","journal-title":"Ophthalmic Genet."},{"key":"34037_CR9","doi-asserted-by":"publisher","unstructured":"Abramson, D. H. et al. Intravitreal chemotherapy in retinoblastoma: expanded use beyond intravitreal seeds. Br. J. Ophthalmol. bjophthalmol-2018-312037, https:\/\/doi.org\/10.1136\/bjophthalmol-2018-312037 (2018).","DOI":"10.1136\/bjophthalmol-2018-312037"},{"issue":"1689","key":"34037_CR10","first-page":"1689.e1681","volume":"118","author":"T Kivela","year":"2011","unstructured":"Kivela, T., Eskelin, S. & Paloheimo, M. Intravitreal methotrexate for retinoblastoma. Ophthalmology 118(1689), 1689.e1681\u20131686 (2011).","journal-title":"Ophthalmology"},{"key":"34037_CR11","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1001\/jamaophthalmol.2014.414","volume":"132","author":"F Ghassemi","year":"2014","unstructured":"Ghassemi, F., Shields, C. L., Ghadimi, H., Khodabandeh, A. & Roohipoor, R. Combined intravitreal melphalan and topotecan for refractory or recurrent vitreous seeding from retinoblastoma. JAMA Ophthalmol. 132, 936\u2013941 (2014).","journal-title":"JAMA Ophthalmol."},{"key":"34037_CR12","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.ccr.2011.07.005","volume":"20","author":"J McEvoy","year":"2011","unstructured":"McEvoy, J. et al. Coexpression of normally incompatible developmental pathways in retinoblastoma genesis. Cancer Cell 20, 260\u2013275 (2011).","journal-title":"Cancer Cell"},{"key":"34037_CR13","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1159\/000370157","volume":"1","author":"RM Nair","year":"2015","unstructured":"Nair, R. M. & Vemuganti, G. K. Transgenic Models in RetinoblastomaResearch. Ocul. Oncol. Pathol. 1, 207\u2013213 (2015).","journal-title":"Ocul. Oncol. Pathol."},{"key":"34037_CR14","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.ccr.2004.05.025","volume":"5","author":"D Chen","year":"2004","unstructured":"Chen, D. et al. Cell-specific effects of RB or RB\/p107 loss on retinal development implicate an intrinsically death-resistant cell-of-origin in retinoblastoma. Cancer Cell 5, 539\u2013551 (2004).","journal-title":"Cancer Cell"},{"key":"34037_CR15","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1101\/gad.1203304","volume":"18","author":"D MacPherson","year":"2004","unstructured":"MacPherson, D. et al. Cell type-specific effects of Rb deletion in the murine retina. Genes Dev. 18, 1681\u20131694 (2004).","journal-title":"Genes Dev."},{"key":"34037_CR16","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.neuron.2017.04.022","volume":"94","author":"I Aldiri","year":"2017","unstructured":"Aldiri, I. et al. The dynamic epigenetic landscape of the retina during development, reprogramming, and tumorigenesis. Neuron 94, 550\u2013568.e510 (2017).","journal-title":"Neuron"},{"key":"34037_CR17","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.cell.2009.03.051","volume":"137","author":"XL Xu","year":"2009","unstructured":"Xu, X. L. et al. Retinoblastoma has properties of a cone precursor tumor and depends upon cone-specific MDM2 signaling. Cell 137, 1018\u20131031 (2009).","journal-title":"Cell"},{"key":"34037_CR18","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/nature13813","volume":"514","author":"XL Xu","year":"2014","unstructured":"Xu, X. L. et al. Rb suppresses human cone-precursor-derived retinoblastoma tumours. Nature 514, 385\u2013388 (2014).","journal-title":"Nature"},{"key":"34037_CR19","doi-asserted-by":"publisher","first-page":"844","DOI":"10.18632\/oncotarget.1051","volume":"4","author":"CA Benavente","year":"2013","unstructured":"Benavente, C. A. et al. Cross-species genomic and epigenomic landscape of retinoblastoma. Oncotarget 4, 844\u2013859 (2013).","journal-title":"Oncotarget."},{"key":"34037_CR20","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nature10733","volume":"481","author":"J Zhang","year":"2012","unstructured":"Zhang, J. et al. A novel retinoblastoma therapy from genomic and epigenetic analyses. Nature 481, 329\u2013334 (2012).","journal-title":"Nature"},{"key":"34037_CR21","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.molmed.2017.02.007","volume":"23","author":"D Dutta","year":"2017","unstructured":"Dutta, D., Heo, I. & Clevers, H. Disease Modeling in Stem Cell-Derived 3D Organoid Systems. Trends Mol. Med. 23, 393\u2013410 (2017).","journal-title":"Trends Mol. Med."},{"key":"34037_CR22","doi-asserted-by":"publisher","first-page":"3504","DOI":"10.1002\/stem.2122","volume":"33","author":"R Kaewkhaw","year":"2015","unstructured":"Kaewkhaw, R. et al. Transcriptome dynamics of developing photoreceptors in Three\u2010dimensional retina cultures recapitulates temporal sequence of human cone and rod differentiation revealing cell surface markers and gene networks. Stem Cells 33, 3504\u20133518 (2015).","journal-title":"Stem Cells"},{"key":"34037_CR23","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/ncb3312","volume":"18","author":"A Fatehullah","year":"2016","unstructured":"Fatehullah, A., Tan, S. H. & Barker, N. Organoids as an in vitro model of human development and disease. Nat. Cell Biol. 18, 246\u2013254 (2016).","journal-title":"Nat. Cell Biol."},{"key":"34037_CR24","doi-asserted-by":"publisher","first-page":"ORSFl1","DOI":"10.1167\/iovs.15-17639","volume":"57","author":"R Kaewkhaw","year":"2016","unstructured":"Kaewkhaw, R. et al. Treatment paradigms for retinal and macular diseases using 3-D retina cultures derived from human reporter pluripotent stem cell lines. Invest. Ophthalmol. Vis. Sci. 57, ORSFl1\u2013ORSFl11 (2016).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"34037_CR25","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.celrep.2017.06.045","volume":"20","author":"H Shimada","year":"2017","unstructured":"Shimada, H. et al. In vitro Modeling using ciliopathy-patient-derived cells reveals distinct cilia dysfunctions caused by CEP290 Mutations. Cell Rep. 20, 384\u2013396 (2017).","journal-title":"Cell Rep."},{"key":"34037_CR26","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.cell.2015.03.053","volume":"161","author":"M van de Wetering","year":"2015","unstructured":"van de Wetering, M. et al. Prospective derivation of a living organoid biobank of colorectal cancer patients. Cell 161, 933\u2013945 (2015).","journal-title":"Cell"},{"key":"34037_CR27","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.stem.2016.04.003","volume":"18","author":"M Fujii","year":"2016","unstructured":"Fujii, M. et al. A colorectal tumor organoid library demonstrates progressive loss of niche factor requirements during tumorigenesis. Cell Stem Cell 18, 827\u2013838 (2016).","journal-title":"Cell Stem Cell"},{"key":"34037_CR28","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.cell.2017.11.010","volume":"172","author":"N Sachs","year":"2018","unstructured":"Sachs, N. et al. A living biobank of breast cancer organoids captures disease heterogeneity. Cell 172, 373\u2013386.e310 (2018).","journal-title":"Cell"},{"key":"34037_CR29","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1038\/nm.4438","volume":"23","author":"L Broutier","year":"2017","unstructured":"Broutier, L. et al. Human primary liver cancer-derived organoid cultures for disease modeling and drug screening. Nat. Med. 23, 1424\u20131435 (2017).","journal-title":"Nat. Med."},{"key":"34037_CR30","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.cell.2014.08.016","volume":"159","author":"D Gao","year":"2014","unstructured":"Gao, D. et al. Organoid cultures derived from patients with advanced prostate cancer. Cell 159, 176\u2013187 (2014).","journal-title":"Cell"},{"key":"34037_CR31","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.stem.2017.12.009","volume":"22","author":"T Seino","year":"2018","unstructured":"Seino, T. et al. Human pancreatic tumor organoids reveal loss of stem Cell niche factor dependence during disease progression. Cell Stem Cell 22, 454\u2013467.e456 (2018).","journal-title":"Cell Stem Cell"},{"key":"34037_CR32","doi-asserted-by":"publisher","first-page":"4550","DOI":"10.1167\/iovs.03-0460","volume":"44","author":"V Traverso","year":"2003","unstructured":"Traverso, V., Kinkl, N., Grimm, L., Sahel, J. & Hicks, D. Basic fibroblast and epidermal growth factors stimulate survival in adult porcine photoreceptor cell cultures. Invest. Ophthalmol. Vis. Sci. 44, 4550\u20134558 (2003).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"34037_CR33","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1016\/j.ophtha.2017.04.015","volume":"124","author":"AL Amram","year":"2017","unstructured":"Amram, A. L. et al. Vitreous seeds in retinoblastoma: clinicopathologic classification and correlation. Ophthalmology 124, 1540\u20131547 (2017).","journal-title":"Ophthalmology"},{"key":"34037_CR34","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1167\/iovs.05-0093","volume":"46","author":"MR Roberts","year":"2005","unstructured":"Roberts, M. R., Hendrickson, A., McGuire, C. R. & Reh, T. A. Retinoid X receptor \u03b3 is necessary to establish the S-opsin gradient in cone photoreceptors of the developing mouse retina. Ophthalmol. Vis. Sci. 46, 2897\u20132904 (2005).","journal-title":"Ophthalmol. Vis. Sci."},{"key":"34037_CR35","doi-asserted-by":"publisher","first-page":"11118","DOI":"10.1523\/JNEUROSCI.1709-11.2011","volume":"31","author":"L Ng","year":"2011","unstructured":"Ng, L. et al. Two transcription factors can direct three photoreceptor outcomes from rod precursor cells in mouse retinal development. J. Neurosci. 31, 11118\u201311125 (2011).","journal-title":"J. Neurosci."},{"key":"34037_CR36","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1002\/gcc.20457","volume":"46","author":"TW Corson","year":"2007","unstructured":"Corson, T. W. & Gallie, B. L. One hit, two hits, three hits, more? Genomic changes in the development of retinoblastoma. Genes Chromosomes Cancer 46, 617\u2013634 (2007).","journal-title":"Genes Chromosomes Cancer"},{"key":"34037_CR37","doi-asserted-by":"publisher","first-page":"438","DOI":"10.18632\/oncotarget.1686","volume":"5","author":"J McEvoy","year":"2014","unstructured":"McEvoy, J. et al. RB1 gene inactivation by chromothripsis in human retinoblastoma. Oncotarget 5, 438\u2013450 (2014).","journal-title":"Oncotarget"},{"key":"34037_CR38","doi-asserted-by":"publisher","first-page":"e0153323","DOI":"10.1371\/journal.pone.0153323","volume":"11","author":"IE Kooi","year":"2016","unstructured":"Kooi, I. E. et al. A Meta-analysis of retinoblastoma copy numbers refines the list of possible driver genes involved in tumor progression. PLoS One 11, e0153323 (2016).","journal-title":"PLoS One."},{"key":"34037_CR39","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.devcel.2017.10.029","volume":"43","author":"A Hoshino","year":"2017","unstructured":"Hoshino, A. et al. Molecular anatomy of the developing human retina. Dev. Cell 43, 763\u2013779.e764 (2017).","journal-title":"Dev. Cell"},{"key":"34037_CR40","doi-asserted-by":"publisher","first-page":"e63519","DOI":"10.1371\/journal.pone.0063519","volume":"8","author":"WS Bond","year":"2013","unstructured":"Bond, W. S. et al. Tumorspheres but not adherent cells derived from retinoblastoma tumors are of malignant origin. PLoS One 8, e63519 (2013).","journal-title":"PLoS One."},{"key":"34037_CR41","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/bjc.2013.283","volume":"109","author":"G Kapatai","year":"2013","unstructured":"Kapatai, G. et al. Gene expression profiling identifies different sub-types of retinoblastoma. Br. J. Cancer 109, 512\u2013525 (2013).","journal-title":"Br. J. Cancer"},{"key":"34037_CR42","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.ebiom.2015.06.022","volume":"2","author":"IE Kooi","year":"2015","unstructured":"Kooi, I. E. et al. Loss of photoreceptorness and gain of genomic alterations in retinoblastoma reveal tumor progression. EBioMedicine 2, 660\u2013670 (2015).","journal-title":"EBioMedicine"},{"key":"34037_CR43","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","volume":"139","author":"JP Thiery","year":"2009","unstructured":"Thiery, J. P., Acloque, H., Huang, R. Y. J. & Nieto, M. A. Epithelial-mesenchymal transitions in development and disease. Cell 139, 871\u2013890 (2009).","journal-title":"Cell"},{"key":"34037_CR44","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/ncb3478","volume":"19","author":"A Labernadie","year":"2017","unstructured":"Labernadie, A. et al. A mechanically active heterotypic E-cadherin\/N-cadherin adhesion enables fibroblasts to drive cancer cell invasion. Nat. Cell Biol. 19, 224 (2017).","journal-title":"Nat. Cell Biol."},{"key":"34037_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-07144-5","volume":"7","author":"N Nair","year":"2017","unstructured":"Nair, N. et al. A cancer stem cell model as the point of origin of cancer-associated fibroblasts in tumor microenvironment. Sci. Rep. 7, 6838 (2017).","journal-title":"Sci. Rep."},{"key":"34037_CR46","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/nature12625","volume":"501","author":"RA Burrell","year":"2013","unstructured":"Burrell, R. A., McGranahan, N., Bartek, J. & Swanton, C. The causes and consequences of genetic heterogeneity in cancer evolution. Nature 501, 338\u2013345 (2013).","journal-title":"Nature"},{"key":"34037_CR47","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1038\/onc.2016.350","volume":"36","author":"DL Qi","year":"2017","unstructured":"Qi, D. L. & Cobrinik, D. MDM2 but not MDM4 promotes retinoblastoma cell proliferation through p53-independent regulation of MYCN translation. Oncogene 36, 1760\u20131769 (2017).","journal-title":"Oncogene"},{"key":"34037_CR48","doi-asserted-by":"publisher","first-page":"6838","DOI":"10.1158\/0008-5472.CAN-16-3299","volume":"77","author":"XL Xu","year":"2017","unstructured":"Xu, X. L. et al. SKP2 Activation by thyroid hormone receptor \u03b22 Bypasses Rb-dependent proliferation in Rb-deficient cells. Cancer Res. 77, 6838\u20136850 (2017).","journal-title":"Cancer Res."},{"key":"34037_CR49","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.exer.2013.01.002","volume":"108","author":"E Buitrago","year":"2013","unstructured":"Buitrago, E. et al. Ocular and systemic toxicity of intravitreal topotecan in rabbits for potential treatment of retinoblastoma. Exp. Eye Res. 108, 103\u2013109 (2013).","journal-title":"Exp. Eye Res."},{"key":"34037_CR50","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1038\/sj.bjc.6600889","volume":"88","author":"GP Feeney","year":"2003","unstructured":"Feeney, G. P. et al. Tracking the cell cycle origins for escape from topotecan action by breast cancer cells. Br. J. Cancer 88, 1310\u20131317 (2003).","journal-title":"Br. J. Cancer"},{"key":"34037_CR51","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1158\/1535-7163.MCT-15-0598","volume":"15","author":"D Onion","year":"2016","unstructured":"Onion, D. et al. 3-Dimensional patient-derived lung cancer assays reveal resistance to standards-of-care promoted by stromal cells but sensitivity to histone deacetylase inhibitors. Mol. Cancer Ther. 15, 753 (2016).","journal-title":"Mol. Cancer Ther."},{"key":"34037_CR52","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1097\/JTO.0b013e3181f8a1bd","volume":"6","author":"RM Bremnes","year":"2011","unstructured":"Bremnes, R. M. et al. The role of tumor stroma in cancer progression and prognosis: emphasis on carcinoma-associated fibroblasts and non-small Cell lung cancer. J. Thorac. Oncol. 6, 209\u2013217 (2011).","journal-title":"J. Thorac. Oncol."},{"key":"34037_CR53","doi-asserted-by":"publisher","first-page":"424","DOI":"10.2353\/ajpath.2010.090512","volume":"177","author":"XL Xu","year":"2010","unstructured":"Xu, X. L. et al. Tumor-associated retinal astrocytes promote retinoblastoma cell proliferation through production of IGFBP-5. Am. J. Clin. Pathol. 177, 424\u2013435 (2010).","journal-title":"Am. J. Clin. Pathol."},{"key":"34037_CR54","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.conb.2012.02.005","volume":"22","author":"M Eiraku","year":"2012","unstructured":"Eiraku, M. & Sasai, Y. Self-formation of layered neural structures in three-dimensional culture of ES cells. Curr. Opin. Neurobiol. 22, 768\u2013777 (2012).","journal-title":"Curr. Opin. Neurobiol."},{"key":"34037_CR55","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/nature20168","volume":"539","author":"N Gjorevski","year":"2016","unstructured":"Gjorevski, N. et al. Designer matrices for intestinal stem cell and organoid culture. Nature 539, 560 (2016).","journal-title":"Nature"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-34037-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-34037-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-34037-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T10:48:07Z","timestamp":1671619687000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-34037-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,23]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["34037"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-34037-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,23]]},"assertion":[{"value":"22 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"15664"}}